EFCCA is actively engaged in seven large-scale EU-funded research projects under the Innovative Medicine Initiative and Horizon Europe programmes. EFCCA’s participation in these projects highlights our commitment to advancing research and addressing the unique needs and interests of patients with Inflammatory Bowel Disease (IBD).
Each of these projects takes an innovative approach to tackling issues that matter most to the IBD community, including exploring new treatments, identifying risk factors and enhancing overall patient support. EFCCA’s involvement ensures that the voice of IBD patients is well-represented and that research efforts stay closely aligned with the real-world experiences and needs of the IBD community.
The ultimate objective is clear: by supporting these forward-thinking research initiatives, EFCCA aims to help improve the quality of life for those affected by IBD, contributing to a future with more effective treatments, better care pathways and greater patient empowerment. Recent advancements within EFCCA’s Horizon Europe projects demonstrate meaningful strides in IBD treatment, emphasising the impact that collaborative research can achieve.
For the latest updates on EFCCA’s involvement and achievements in Horizon Europe and Horizon 2020 programmes, explore our EFCCA PROJECTS DIGEST newsletter, where you’ll find fresh insights and developments in IBD research: www.efcca.org/projects/efcca-projects-digest-newsletter